Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo.
暂无分享,去创建一个
Hui-Ling Wang | Liang Chen | Hui-Juan Wang | Wenli Xie | Yunyi Yao | Yan-Shan Zhang | Huiling Wang | Yunyi Yao | Yanshan Zhang | Huiling Wang | Huijuan Wang | Liang Chen | Wenli Xie
[1] A. Yılmaz,et al. Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis‐related markers: caspase‐3, bcl‐2, and p53 , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[2] Xu Yuxian,et al. Tanshinone II-A Inhibits Invasion and Metastasis of Human Hepatocellular Carcinoma Cells in Vitro and in Vivo , 2009, Tumori.
[3] K. Lee,et al. New developments in the chemistry and biology of the bioactive constituents of tanshen , 2007, Medicinal research reviews.
[4] D. Stocum,et al. Cell cycle regulation and regeneration. , 2013, Current topics in microbiology and immunology.
[5] Jia Yu,et al. Novel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells. , 2013, The American journal of Chinese medicine.
[6] S. Barillé-Nion,et al. Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy. , 2012, Anticancer research.
[7] C. Cotman,et al. Caspase-3 activation as a bifurcation point between plasticity and cell death , 2012, Neuroscience Bulletin.
[8] B. Snel,et al. Evolution and function of the mitotic checkpoint. , 2012, Developmental cell.
[9] Min Xu,et al. Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[10] Jae Heun Lee,et al. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. , 2008, International journal of oncology.
[11] W. El-Deiry,et al. p21WAF1 and tumourigenesis: 20 years after , 2013, Current opinion in oncology.
[12] M. Rebucci,et al. Molecular aspects of cancer cell resistance to chemotherapy. , 2013, Biochemical pharmacology.
[13] T. Miyazaki,et al. Two Distinct Controls of Mitotic Cdk1/Cyclin B1 Activity Requisite for Cell Growth Prior to Cell Division , 2007, Cell cycle.
[14] Yunyi Yao,et al. Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[15] X. Jiang,et al. Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. , 2012, Experimental oncology.
[16] Z. Darżynkiewicz,et al. Cytometry of apoptosis. Historical perspective and new advances. , 2012, Experimental oncology.
[17] A. Cataldi,et al. Cyclin-Dependent Kinase Modulators and Cancer Therapy , 2012, BioDrugs.
[18] P. Lyu,et al. Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells , 2010, Proteomics.
[19] Jian Yong Wu,et al. Tanshinone biosynthesis in Salvia miltiorrhiza and production in plant tissue cultures , 2010, Applied Microbiology and Biotechnology.
[20] Å. Gustafsson,et al. Mitochondria and Mitophagy: The Yin and Yang of Cell Death Control , 2012, Circulation research.